Dr. Haince, holds a PhD in Cellular and Molecular Biology from the Faculty of Medicine at Université Laval. He cumulates over 20 years of experience in cancer research and has authored over 25 peer-reviewed scientific publications. He is currently the General Manager and CSO of BioMark Diagnostics, a company that is developing a cancer diagnostic technology which combines metabolomics and machine learning. Dr. Haince also managed a multidisciplinary team of experts at the Université Laval, technology transfer office. His role was to provide advice and project management support for the development and deployment of cutting-edge research innovations. During his term at DiagnoCure, he was responsible for the development of new molecular diagnostic tests, from product design to clinical validation.